Newark, CA, United States of America

Vioptix, Inc.


USPTO Granted Patents = 187



Trademarks = 3

Forward Citations = 1,449

Loading Chart...
Loading Chart...

66 inventors (with patents filed for the assignee):

goldMedal Robert E Lash (98 out of 98 patents)

silverMedal Jimmy Jian-min Mao (81 out of 81 patents)

bronzeMedal Kate LeeAnn Bechtel (60 out of 95 patents)

4.  Scott Coleridge (33 out of 33 patents)

5.  Larry C Heaton, Ii (28 out of 31 patents)

6.  Alex Michael Margiott (22 out of 22 patents)

7.  Mark Lonsinger (17 out of 17 patents)

8.  Joseph A Heanue (16 out of 49 patents)

9.  William Welch (14 out of 16 patents)

10.  Alan Baldwin (12 out of 30 patents)

11.  Lester John Lloyd (11 out of 49 patents)

12.  Edward Gerald Solomon (11 out of 47 patents)

13.  Sophia Elizabeth Berger (10 out of 10 patents)

14.  H Keith Nishihara (9 out of 37 patents)

15.  Jennifer Elizabeth Keating (9 out of 9 patents)


Core Competencies:
Oximeter
Tissue Saturation
Melanin Correction
Wireless Probe
Laparoscopic Extension
Depth Analysis
Calibration
Quality Reporting
Surgical Detection
Real-Time Measurement
Noninvasive Sensor
Probe Assembly

187 patents:

Vioptix, Inc. is a technology company based in Newark, California, specializing in tissue oximetry solutions. The organization develops advanced oximeters that provide critical insights into tissue saturation levels, utilizing innovative features such as melanin correction and wireless probes. Their technology is designed to enhance depth analysis and calibration processes, ensuring accurate quality reporting in medical applications. Vioptix aims to improve patient outcomes through precise monitoring of tissue oxygenation, particularly in surgical and clinical settings.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

Vioptix, Inc.
187 Patents

#3 in Newark, CA

#478 in California

#2,192 in US

#4,495 in the World

Newark, CA (US)
Newark, CA, United States of America
Forward Citations = 1,449

66 inventors:

Please report any incorrect information to [email protected]
Loading…